Your browser doesn't support javascript.
loading
Determinants of post discharge mortality among hospitalized COVID-19 patients.
Kumar, Gunjan; Talukdar, Arunansu; Turuk, Alka; Bhalla, Ashish; Mukherjee, Subhasis; Bhardwaj, Pankaj; Bhatnagar, Tarun; Mukherjee, Aparna.
Afiliação
  • Kumar G; Clinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
  • Talukdar A; Department of Geriatric Medicine, Medical College & Hospital, Kolkata, West Bengal, India.
  • Turuk A; Clinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
  • Bhalla A; Department of Internal Medicine, Institute of Medical Education & Research, Chandigarh, India.
  • Mukherjee S; Department of Respiratory Medicine, College of Medicine & Sagore Dutta Hospital, Kolkata, West Bengal, India.
  • Bhardwaj P; Department of Community Medicine and Family Medicine, School of Public Health, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
  • Bhatnagar T; School of Public Health, ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu, India.
  • Mukherjee A; Clinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
Indian J Med Res ; 158(2): 136-144, 2023 08.
Article em En | MEDLINE | ID: mdl-37675689
ABSTRACT
Background &

objectives:

The post-acute effects of COVID-19 are continually being updated. This investigation was conducted to evaluate the determinants of post discharge mortality in hospitalized COVID-19 patients, especially 18-45 yr of age.

Methods:

A series of three nested case-control analyses was conducted on follow up data collected in the National Clinical Registry for COVID-19 between September 2020 and February 2023 from 31 hospitals. Matching (14) was done by the date of hospital admission ±14 days for the following comparisons (i) case-patients reported as dead vs. controls alive at any contact within one year follow up; (ii) the same in the 18-45 yr age group and (iii) case-patients reported as dead between the first and one year of follow up vs. controls alive at one year post discharge.

Results:

The one year post discharge mortality was 6.5 per cent (n=942). Age [≤18 yr adjusted odds ratio (aOR) (95% confidence interval [CI]) 1.7 (1.04, 2.9); 40-59 yr aOR (95% CI) 2.6 (1.9, 3.6); ≥60 yr aOR (95% CI) 4.2 (3.1, 5.7)], male gender [aOR (95% CI) 1.3 (1.1, 1.5)], moderate-to-severe COVID-19 [aOR (95% CI) 1.4 (1.2, 1.8)] and comorbidities [aOR (95%CI) 1.8 (1.4, 2.2)] were associated with higher odds of post-discharge one-year mortality, whereas 60 per cent protection was conferred by vaccination before the COVID-19 infection. The history of moderate-to-severe COVID-19 disease [aOR (95% CI) 2.3 (1.4, 3.8)] and any comorbidities [aOR (95% CI) 3 (1.9, 4.8)] were associated with post-discharge mortality in the 18-45-yr age bracket as well. Post COVID condition (PCC) was reported in 17.1 per cent of the participants. Death beyond the first follow up was associated with comorbidities [aOR (95%CI) 9.4 (3.4, 26.1)] and reported PCC [aOR (95% CI) 2.7 (1.2, 6)]. Interpretation &

conclusions:

Prior vaccination protects against post discharge mortality till one year in hospitalized COVID-19 patients. PCC may have long term deleterious effects, including mortality, for which further research is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article